STADA Arzneimittel Overview
- Founded
-
1895
- Status
-
Private
- Employees
-
13,183
- Latest Deal Type
-
Buyout/LBO
- (Cancelled)
- Financing Rounds
-
9
- Investments
-
38
STADA Arzneimittel General Information
Description
STADA Arzneimittel AG is a specialty and generic drug manufacturing company. The vast majority of the company's sales are derived from its generic drug products, followed by its branded products. It operates in three segments: Generics, Consumer Healthcare, and Specialty. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Contact Information
Website
www.stada.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Drug Discovery
Former Stock Listing
SAZD
Primary Office
- Stadastraße 2-18
- 61118 Bad Vilbel
- Germany
+49 06101 0000
STADA Arzneimittel Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
STADA Arzneimittel Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
STADA Arzneimittel AG is a specialty and generic drug manufacturing company. The vast majority of the company's sales ar
Pharmaceuticals
Bad Vilbel, Germany
13,183
As of 2022
000000000000
000000
iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
000000000000000
Tokyo, Japan
00000
As of 0000
00000000
00000
on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 000000000
Mumbai, India
00000
As of 0000
00000000
Add Comparison
STADA Arzneimittel Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Astellas Pharma | Corporation | Tokyo, Japan | 00000 | 00000000 | ||
| 00000 | Corporation | Mumbai, India | 00000 | 00000000 | ||
| 0000000000 0000000 | Corporation | Neufeld an der Leitha, Austria | 000 | 000.00 | 000000&0 | |
| 000000 00000 | Corporation | Mumbai, India | 0000 | |||
| 000 000000 | Corporate Backed or Acquired | Monheim, Germany | 0000 | 000000&0 |
STADA Arzneimittel Patents
STADA Arzneimittel Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4046626-A1 | Use of a pemetrexed concentrate solution | Pending | 21-Feb-2021 | 0000000000 | 0 |
| EP-3456319-A1 | Dpp-4-inhibitor-composition | Pending | 15-Sep-2017 | 0000000000 | 0 |
| EP-3456320-A1 | Dpp-4-inhibitor-mono-composition | Pending | 15-Sep-2017 | 0000000000 | 0 |
| EP-3618812-A1 | Orodispersible tablet containing an h1 antihistamine | Pending | 02-May-2017 | 0000000000 | |
| EP-3398590-A1 | Orally disintegrating tablet, containing a h1-antihistamine | Inactive | 02-May-2017 | A61K9/0056 | 0 |
STADA Arzneimittel Executive Team (28)
STADA Arzneimittel Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0ü0000 00 00.0 | STADA Arzneimittel | Chairman of the Supervisory Board | 000 0000 |
| 00000 0000 | STADA Arzneimittel | Deputy Chairman Supervisory Board, R & D | 000 0000 |
| 00000 00000000000 | STADA Arzneimittel | Chief Executive Officer & Chairman Executive Board | 000 0000 |
STADA Arzneimittel Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
STADA Arzneimittel Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
STADA Arzneimittel Investments & Acquisitions (38)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 000 | 23-Dec-2022 | 0000000000 | Distributors/Wholesale | ||
| 000000 (00 00 | 28-Jun-2021 | 0000000000 | 00000 | Pharmaceuticals | 00000 000 |
| 000000 000000 | 02-Oct-2020 | 0000000000 | 00000 | Pharmaceuticals | 00000 000 |
| 0000000000000 | 12-Jun-2020 | 000000000 | 00000 | Buildings and Property | 00000 000 |
| Xbrane Biopharma | 20-May-2020 | PIPE | 000.00 | Biotechnology |
STADA Arzneimittel Subsidiaries (11)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Lobsor Pharmaceuticals | Pharmaceuticals | Uppsala, Sweden | 2013 |
| 0000000 0000000000 | Other Devices and Supplies | Tulln, Austria | 0000 |
| 00000 000 | Distributors/Wholesale | Zagreb, Croatia | 0000 |
| 0000000 | Pharmaceuticals | Trinec, Czech Republic | 0000 |
| 00000 000000 | Pharmaceuticals | Laichingen, Germany | 0000 |
STADA Arzneimittel Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000000 | 01-Jan-2013 | 000000000000000000 | Completed |
|
|
| 0000000000 | 01-Jan-2010 | 000000000 | 0000 | Completed |
|
| 0000000000 | 01-Jan-2008 | 000000000 | 00.000 | Completed |
|
| 00000000 | 26-Feb-2004 | 000000000 | 00.000 | Completed |
|
| Sirton Pharmaceuticals | 17-May-2002 | Merger/Acquisition | Completed |